Parenteral Delivery of Peptides and Proteins - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 599

[175] Guobao W, Glenda JP, McCauley LK, Ma PX. The release profiles and bioactivity of
parathyroid hormone from poly(lactic- co -glycolic acid) microspheres. Biomaterials
2004;25:345-52.
[176] Bilati U, Pasquarello C, Corthals GL, Hochstrasser DF, Mann EA, Doelker E. Matrix-
assisted laser desorption/ionization time-of-flight mass spectrometry for quantitation
and molecular stability assessment of insulin entrapped within PLGA nanoparticles.
J Pharm Sci 2005;94:1-7.
[177] Somnath S, Jagdish S. Phase-sensitive polymer-based controlled delivery systems of
leuprolide acetate: in vitro release, biocompatibility, and in vivo absorption in rabbits.
Int J Pharm 2007;328:42-8.
[178] Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. In vitro drug release behaviour of
D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a
novel spontaneous emulsification solvent diffusion method. J Pharm Sci 1994;83:727-32.
[179] Kostanski JW, Thanoo BC, DeLuca PP. Preparation, characterization, and in vitro
evaluation of 1- and 4-month controlled release Orntide PLA and PLGA microspheres.
Pharm Dev Technol 2000;5:585-96.
[180] Ginty PJ, Whitaker MJ, Shakesheff KA, Howdle SM. Drug delivery goes supercritical.
Mater Today 2005;8:42-8.
[181] Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, et al. PEGylated polycyanoacrylate
nanoparticles as tumor necrosis factor- carriers. J Control Release 2001;71:287-96.
[182] Cleland JL, Duenas ET, Park A, Daugherty A, Kahn J, Kowalski J, et al. Development of
poly (D,L-lactide- co -glycolide) microsphere formulations containing recombinant human
vascular endothelial growth factor to promote local angiogenesis. J Control Release 2001;72:
13-24.
[183] Péan JM, Menei P, Morel O, Montero-Menei CN, Benoit JP. Intraseptal implantation of
NGF-releasing microspheres promote the survival of axotomized cholinergic neurons.
Biomaterials 2000;21:2097-101.
[184] Horvath JE, Bajo AM, Schally AV, Kovacs M, Herbert F, Groot K. Effects of long-term
treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl
and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their
mRNA expression in rats. Proc Natl Acad Sci USA 2002;99:15048-53.
[185] Sinha VR, Trehan M. Biodegradable microspheres for protein delivery. J Control
Release 2003;90:261-80.
[186] Heya T, Okada H, Ogawa Y, Toguchi H. In vitro and in vivo evaluation of thyrotrophin
releasing hormone release from copoly(DL-lactic/glycolic acid) microspheres. J Pharm
Sci 1994;83:636-40.
[187] Han K, Lee KD, Gao ZG, Park JS. Preparation and evaluation of poly(L-lactic acid)
microspheres containing rhEGF for chronic gastric ulcer healing. J Control Release
2001;75:259-69.
[188] Gibaud S, Rousseau C, Weingarten C, Favier R, Douay L, Andreux JP, et al.
Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating fac-
tor (G-CSF). J Control Release 1998;52:131-9.
[189] Yang J, Cleland JL. Factors affecting the in vitro release of recombinant human inter-
feron- (rhIFN-) from PLGA microspheres. J Pharm Sci 1997;86:908-14.
[190] Couvreur P, BlancoPrieto MJ, Puisieux F, Roques B, Fattal E. Multiple emulsion tech-
nology for the design of microspheres containing peptides and oligopeptides. Adv Drug
Delivery Rev 1997;28:85-96.
[191] Supersaxo A, Kou JH, Teitelbaum P, Maskiewicz R. Preformed porous microspheres for
controlled and pulsed release of macromolecules. J Control Release 1993;23:157-64.